Profile
Ginny Blocki is currently the SVP-Product Management & Global Marketing at Embecta Corp.
Prior to this, she held positions such as Head-Global Marketing Molecular Diagnostics at Abbott Laboratories, Head-US Medication Delivery Marketing at Baxter International, Inc., SVP-Product Management & Global Marketing at Becton, Dickinson & Co., Vice President-Specialty Products at Assertio Therapeutics, Inc., and Vice President & Head-Global Marketing Immunology at Baxalta, Inc. She completed her undergraduate degree at Indiana University.
Ginny Blocki active positions
Companies | Position | Start |
---|---|---|
EMBECTA CORP. | Sales & Marketing | 22/03/2022 |
Former positions of Ginny Blocki
Companies | Position | End |
---|---|---|
BECTON, DICKINSON AND COMPANY | Sales & Marketing | 01/03/2022 |
BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/10/2021 |
BAXALTA INC | Sales & Marketing | - |
ABBOTT LABORATORIES | Sales & Marketing | - |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Corporate Officer/Principal | - |
Training of Ginny Blocki
Indiana University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
EMBECTA CORP. | Health Technology |
BECTON, DICKINSON AND COMPANY | Health Technology |
BAXTER INTERNATIONAL INC. | Health Technology |
ABBOTT LABORATORIES | Health Technology |
Private companies | 2 |
---|---|
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Baxalta, Inc.
Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
- Stock Market
- Insiders
- Ginny Blocki